Dr. Prashant.C.Dheerendra
1.2K posts

Dr. Prashant.C.Dheerendra
@prashantnephro
Kidney doctor. Founder of Dharma Kidney Care. Adjunct associate professor at Apollo Hospitals,BG Road, Bangalore. Making life easier for kidney patients.




See you on the other side 🦋 nephjc.com/news/2024/11/1… #NephJC #NephSky #SkyNeph



One of the common criticisms of NephroCheck and other biomarkers of AKI is that since we don't have a treatment for AKI, checking these do not change what we do. But I think this view isn't thoughtful. Given that most of the contrast associated nephropathy we see after cardiac cath has been shown to be meaningless hemodynamic changes in creatinine and not actual tubular damage, we could have avoided scaring a generation of doctors in to believing in contrast nephropathy had we evolved from creatinine to biomarkers. Similarly, how many heart failure patients have gotten inadequate diuresis because of panic over a bump in creatinine? I suspect, had we transitioned to biomarkers of kidney injury, cardiologists and nephrologists would have been more confident in pressing forward with needed diuresis. Better diagnosis would allow better management despite not having an AKI pill (yet).




























